Sheila A. Doggrell
Department of Physiology and Pharmacology
School of Biomedical Sciences
The University of Queensland
QLD 4072
Australia
Name/email consistency: high
- Losartan for LIFE in hypertension with left ventricular hypertrophy?. Doggrell, S.A. Expert. Opin. Pharmacother (2003)
- Reviparin as prophylaxis for thromboembolism after leg injury and hip replacement. Doggrell, S.A. Expert. Opin. Pharmacother (2003)
- Is levosimendan a breakthrough in the development of positive inotropes?. Doggrell, S.A. Expert. Opin. Pharmacother (2003)
- ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction?. Doggrell, S.A. Expert. Opin. Pharmacother (2003)
- Warfarin and aspirin give more benefit than aspirin alone but also more bleeding after myocardial infarction. Doggrell, S.A. Expert. Opin. Pharmacother (2003)
- Effects of dofetilide on cardiovascular tissues from normo- and hypertensive rats. Doggrell, S.A., Nand, V. J. Pharm. Pharmacol. (2002)
- Present and future pharmacotherapy for heart failure. Doggrell, S.A., Brown, L. Expert. Opin. Pharmacother (2002)
- Effects of BDF 9198 on left ventricular contractility in advanced spontaneously hypertensive rats with heart failure. Doggrell, S.A. J. Pharm. Pharmacol. (2002)
- Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive rats. Doggrell, S.A. J. Pharm. Pharmacol. (2002)
- Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?. Doggrell, S.A. Expert. Opin. Pharmacother (2002)